Switch to Tirzepatide in T2D More Effective Than Upping Dulaglutide Dose

(MedPage Today) -- Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide (Mounjaro) rather than increasing the dose of the earlier-generation GLP-1 receptor agonist, an open...